GC녹십자 and 한미약품 Export Fabry Disease Drug Technology
GC녹십자 and 한미약품 announced a technology export deal for a Fabry disease drug.
Related stories
Aspen Neuroscience Prices Initial Public Offering
M impact | MNA | Oct 30, 2026, 02:32 AM UTC
Mirae Asset to Enter Japan Retail Brokerage Market With Sanko Acquisition
Mirae Asset will enter Japan’s retail brokerage market through an acquisition of Sanko.
M impact | MNA | Oct 30, 2026, 02:24 AM UTC
DoorDash Plans $17 Billion Acquisition of Instacart
DoorDash CEO Tony Xu said the planned deal could support faster, cheaper grocery delivery through better order accuracy. The acquisition faces FTC scrutiny.
M impact | MNA | Oct 30, 2026, 02:14 AM UTC
CZR Resources Withdraws Offer to Take Over Zuleika Gold
M impact | MNA | Oct 30, 2026, 02:10 AM UTC
ICE Accelerates MarketAxess Acquisition Timeline to Q1 2027
Intercontinental Exchange expects to complete its acquisition of MarketAxess in Q1 2027, advancing its previous timeline of the first half of 2027 after receiving Hart-Scott-Rodino
M impact | MNA | Oct 30, 2026, 02:03 AM UTC
China Evergrande Property Opens 11.4% Lower on PAG Deal
China Evergrande Property opened 11.4% lower. The company said PAG will acquire a majority stake in China Evergrande at a discount.
M impact | MNA | Oct 30, 2026, 01:47 AM UTC